Hemoglobin-vesicles as oxygen carriers: Influence on phagocytic activity and histopathological changes in reticuloendothelial system

American Journal of Pathology

Volumn 159, Issue 3, 2001, Pages 1079-1088

  Sakai, Hiromi ^a   Horinouchi, Hirohisa ^b   Tomiyama, Kenichi ^a   Ikeda, Eiji ^b   Takeoka, Shinji ^a   Kobayashi, Koichi ^b   Tsuchida, Eishun ^a  

^a WASEDA UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; EOSIN; FERRIC FERROCYANIDE; HEMATOXYLIN; HEMOGLOBIN; HEMOSIDERIN; INTRALIPID; IRON; OIL RED O; OXYGEN CARRIER; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HISTOPATHOLOGY; IRON METABOLISM; LIVER; MALE; METABOLISM; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; RAT; RETICULOENDOTHELIAL SYSTEM; SPLEEN;

EID: 0034849666     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61783-X     Document Type: Article

References (65)

1. 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit
2. Physiologic responses to exchange transfusion with hemoglobin vesicles as an artificial oxygen carrier in anesthetized rats: Changes in mean arterial pressure and renal cortical tissue oxygen tension
3. 2 affinity
4. Polyethyleneglycol-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state
5. Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia
6. Diaspirin crosslinked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial
7. A phase I study of oxidized raffinose cross-linked human hemoglobin
8. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery
9. Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: Objective comparison between cellular and acellular types
10. 2 carriers determine constriction of resistance arteries and hypertension in conscious hamster model
11. Distribution of heme oxygenase isoform in rat liver: Topographic basis for carbon monoxide-mediated microvascular relaxation
12. Elimination of pyridoxalated polyhemoglobin after partial exchange transfusion in chimpanzees
13. Physiological responses, organ distribution, and circulation kinetics in anesthetized rats after hypovolemic exchange transfusion with technetium-99m-labeled liposome-encapsulated hemoglobin
14. Liposome-encapsulated hemoglobin: A red blood cell substitute
15. Effects of liposome encapsulated hemoglobin on the reticuloendothelial system
16. The effects of hemoglobin on reticuloendothelial function
17. Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice
18. Acute toxicity and depression of phagocytosis in vivo by liposomes: Influence of lysophosphatidyl choline
19. Intralipid adversely affects reticuloendothelial bacterial clearance
20. Perfluorochemical emulsions decrease Kupffer cell phagocytosis
21. Comparison of particle clearance and macrophage phagosomal motion in liver and lungs of rats
22. Effect of pyridoxalated stabilized stroma-free hemoglobin solution on the clearance of intravascular lipid by the reticuloendothelial system
23. Antineoplastic activity of sterically stabilized alkylphosphbcholine liposomes in human breast carcinomas
24. Influence of polymerizable phospholipid vesicels encapsulated hemoglobin on the murine immune system
25. Biodistribution of the neo red cell and effect on the phagocytic activity of the reticuloendothelial system
26. Influence of Fluosol-DA 20% on reticuloendothelial systems
27. Synthesis and evaluation of a prototypal artificial red cell
28. Cardiorespiratory effects of exchanging transfusions with synthetic erythrocytes in rats
29. Use of oxygen-15 to measure oxygen carrying capacity of blood substitutes in vivo
30. Layercontrolled hemoglobin vesicles by interaction of hemoglobin with a phospholipid assembly
31. Physical properties of hemoglobin vesicles as red cell substitutes
32. Surface modification of hemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma
33. Surface-modification of hemoglobin vesicles with polyethyleneglycol and effects on aggregation, viscosity, and blood flow during 90%-exchange transfusion in anesthetized rats
34. Subcutaneous microvascular responses to hemodilution with red cell substitutes consisting of polyethyleneglycol-modified vesicles encapsulating hemoglobin
35. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids
36. Polyethyleneglycol-modified liposome-encapsulated hemoglobin: A long circulating red cell substitute
37. Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system
38. Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene
39. Ultrastrucrural studies of the interaction between liposome-activated human blood monocytes and allogenic tumor cells in vitro
40. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
41. The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes
42. Liposome disposition in vivo. II: Dose dependency
43. Effect of liposome-encapsulated hemoglobin on the development of endotoxin-induced shock in the rat
44. Diminished bacterial defenses with Intralipid
45. O/W lipid emulsion for parenteral drug delivery III. Lipophylicity necessary for incorporation in oil particles even after intravenous injection
46. The intravenous Intralipid tolerance test
47. Studies on an intravenous fat tolerance test: Methodological, experimental and clinical experiences with Intralipid
48. Effect of liposome size on the circulation time and intraorgan distribution of amphipatic poly(ethylene glycol)-containing liposomes
49. Poly(ethyleneglycol) derivative of cholesterol reduces binding step of liposome uptake by murine macrophage-like cell line J774 and human hepatoma cell line HepG2
50. Histopathological study following administration of liposome-encapsulated hemoglobin in the normovolemic rat
51. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice
52. Increased liposome extravasation in selected tissues: Effect of substance P
53. Characterization of two heme oxygenase isoforms in rat spleen: Comparison with the hematin-induced and constitutive isoforms of the liver
54. Perspectives in iron metabolism
55. Differential hepatic processing and biliary secretion of head-group and acyl chains of liposomal phosphatidylcholines
56. Uptake and processing of liposomal phospholipids by Kuppfer cells in vitro
57. Clearance of tissue distribution of functionalized polymeric liposomes from the blood stream of rats
58. Lipoproteins and liposomes as in vivo cholesterol vehicles in the rat: Preferential use of cholesterol carried by small unilamellar liposomes for the formation of muricholic acids
59. Radiation-induced polymerization of phospholipid mixtures for the synthesis of artificial red blood cells
60. Characteristics of artificial red cells: Hemoglobin encapsulated in poly-lipid vesicles
61. Encapsulation of Hb into unsaturated lipid vesicles and γ-ray polymerization
62. In vitro and in vivo stability of polymerized mixed-liposomes composed of 2,4-octadecadienoyl groups of phospholipids
63. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice